CorMedix Inc. (CRMD)

NASDAQ: CRMD · Real-Time Price · USD

6.37

-0.09 (-1.39%)

At close: Mar 18, 2026, 4:00 PM EDT

6.38

+0.01 (0.15%)

After-hours: Mar 18, 2026, 7:48 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Drug Product	311.71M	43.47M		65.41K	190.94K	239.23K
Drug Product Growth	617.03%	-		-65.74%	-20.19%	-15.55%
Total	311.71M	43.47M		65.41K	190.94K	239.23K
Total Growth	617.03%	-		-65.74%	-20.19%	-15.55%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	311.71M	43.47M		-	-	2.21K
United States Growth	617.03%	-		-	-	-75.00%
Germany	-	-		-	190.94K	237.03K
Germany Growth	-	-		-	-19.44%	-13.63%
Total	311.71M	43.47M		-	190.94K	239.23K
Total Growth	617.03%	-		-	-20.19%	-15.55%

Source: S&P Global Market Intelligence.